Cyclical capex downturn — orders roll over while the stock still carries a ~36× forward multiple
One-line thesis. Rockwell is a genuinely high-quality, wide-moat US automation franchise (52% gross margin, ~30% ROE, growing software/ARR mix) that is executing a clean cyclical recovery — but at ~36× forward earnings for only ~5% revenue growth, the market already pays full price, so we rate it Watch: a name to own on a pullback or an order re-acceleration, not here.
◆ Synthos call — HoldROK is a solid business largely reflected at ~$465 — fine to keep, no reason to chase; it gets interesting again below ~$395.
Downside Risk (lower = safer)
6/10 · High
Beta 1.56 & 2.2× net-debt/EBITDA in a cyclical, priced 36× fwd EPS — rich for mid-single-digit growth.
Growth Quality
5/10 · Moderate
Only ~5% fwd revenue CAGR & ~9% fwd EPS CAGR, but 52% gross margin, 30% ROE and a genuine software/ARR mix-shift.
Exponential Potential
3/10 · Low
Late-cycle industrial compounder, not an exponential; $52B cap in a mature TAM, growth re-accelerating off a trough but not inflecting.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 18%/yrTo justify today’s $472, earnings would have to compound roughly 18% a year for 10 years (9% discount rate). Analysts forecast ~9%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Rockwell Automation makes the "brains and muscles" of factories — the controllers, drives, sensors, and software that run automated production lines for carmakers, food and drink plants, warehouses, chip fabs, and data centers. If a modern factory in North America moves a robot arm or a conveyor, there's a good chance Rockwell gear is behind it. It's a very good business: it keeps about 52 cents of gross profit on every sales dollar and earns high returns.
The catch: the stock is expensive and the business is cyclical — it rises and falls with how much money companies are spending on new factories. Right now spending is recovering, which is good, but you're paying roughly $36 for every $1 of next year's earnings for a company only growing sales about 5% a year. That's a premium price for modest growth. Our verdict is Watch — wait for a better price or faster growth.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). Solid company, but the stock swings more than the market (it's cyclical), carries some debt, and is priced high — so a stumble hurts.
Growth Quality 5/10 (middle). Excellent profitability and a real moat, but the growth is slow and depends on the economy.
Exponential Potential 3/10 (low). This is a steady, mature industrial — not a company that doubles quickly.
The one big worry: factory and capital spending is cyclical. If orders roll over in a slowdown, both earnings and the rich multiple can fall at the same time.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = ROK · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$471.70
Market cap$52B
P/E trailing21×
P/E FY26E / FY27E36× / 32×
EV / Sales6.4×
EV / EBITDA33.9×
Gross margin52.5%
Net margin12.4%
Dividend yield1.16%
Beta1.561
52-wk range$329 – $495
RSI(14)56
50 / 200-DMA$448 / $399
12-mo return+39% (SPY +21%)
Street target$475 ($410–$525)
Analyst grades12 Buy · 25 Hold · 2 Sell
FMP ratingB
Next earnings2026-08-05
What the experts actually said 0 traceable claims on ROK · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Rockwell Automation (NYSE: ROK), founded 1903 and headquartered in Milwaukee, is the largest pure-play industrial-automation company in the US. It sells the hardware, software, and services that automate discrete, hybrid, and process manufacturing — programmable controllers (the Allen-Bradley / Logix franchise), drives and motion, sensing and safety, plus a growing layer of control software, digital-twin/simulation, cybersecurity, and connected lifecycle services. Fiscal year ends September 30. CEO Blake Moret; ~27,000 employees.
Revenue mix (FY2025, from filings):
By segment: Intelligent Devices $3.76B (45%) · Software & Control $2.38B (29%) · Lifecycle Services $2.20B (26%). The mix-shift that matters: Software & Control grew fastest (Q2 FY26 +20% YoY, 35% segment margin) and annual recurring revenue (ARR) grew ~6% YoY — a slow, real pivot from a box-mover toward higher-quality recurring/software economics.
By geography: North America $5.27B (~63%) (US alone ~$4.85B, ~58%) · EMEA $1.49B (18%) · Asia-Pacific $1.02B (12%) · Latin America $0.56B (7%). The base is heavily North-America-weighted, which is a re-shoring/US-capex tailwind but also a concentration risk (§11).
The demand drivers Rockwell keeps naming: warehouse/logistics automation, data-center buildout, semiconductor capacity, and energy — offset by "muted" capital investment in several other verticals.
2. The expert thesis — why the panel is (not) bullish
There is no expert coverage of ROK in the Synthos knowledge base.total_claims = 0, breadth = 0 net-bullish voices, net conviction = 0. No distilled expert has a traceable, dated view on Rockwell in our system.
That matters for honesty: this note carries no conviction-track signal. Every judgment below is derived from the fundamentals (FMP filings), analyst estimates, management's own SEC-filed guidance, and quant/technical data — not from any expert we track. Where the Street has a view we show it as context (a Hold consensus, §6), and we do not dress quant output up as expert conviction. If and when a tracked voice initiates on ROK, this section — and possibly the verdict — will be revisited.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Moderate-High
Beta 1.56 and net-debt/EBITDA ~2.2× in a cyclical business, priced ~36× forward EPS for ~5% revenue growth. Balance sheet is investment-grade and serviceable (interest coverage ~12×), but valuation + cyclicality leave real room to fall in a downturn.
Growth Quality
5 · Average
Only ~5% forward revenue CAGR and ~9% forward EPS CAGR — modest — but 52% gross margin, ~30% ROE, ~16% ROIC, a wide Allen-Bradley moat, and a genuine software/ARR mix-shift lift the quality of that growth well above its rate.
Exponential Potential
3 · Low
A mature, late-cycle industrial compounder. Growth is re-accelerating off a FY25 trough (good) but not inflecting into a new curve; a $52B cap in a mature automation TAM caps the multibagger. Own for durable mid-single-digit compounding, not exponentiality.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Capex cycle inflects up; re-shoring + data-center/semi demand drives organic sales toward the high end; ARR/software mix lifts margins. FY27E adj. EPS beats to ~$16 (vs ~$14.5 cons); market pays a peak-cycle ~36×.
~$585 (+24%)
Base(our anchor)
Estimates roughly hit — FY27E EPS ~$14.5; a high-quality but slow-growth cyclical earns a ~32× forward multiple.
~$465 (−1%)
Bear
Cyclical rollover: capex pauses, organic sales flatten/decline, ARR growth stalls. FY27E EPS misses to ~$12.5; multiple de-rates to a mid-cycle ~28×.
~$355 (−25%)
Synthos fair value = the base case, ~$465 (−1%), with the full $355–$585 span as the honest range. Our base sits essentially on top of the Street's $475 consensus (this is a well-covered, efficiently-priced megacap; we have no differentiated edge to claim), while our bear takes the cyclicality seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). ROK is a high-quality compounder with low exponential potential:
Forward growth (modest): revenue CAGR FY25→FY30E ~5.4% ($8.34B → $10.87B); EPS CAGR off the FY26E base ~9% ($12.98 → $18.49 by FY30E) as margins and mix improve. These are respectable industrial numbers, not exponential ones.
Acceleration (the 2nd derivative) is positive off a trough — but not an inflection. Revenue fell to $8.34B in FY25 (below FY23's $9.06B) as the automation capex cycle bottomed; it now re-accelerates (Q2 FY26 sales +12% reported, +9% organic). This is a cyclical recovery, not a structural new-curve inflection like a genuine exponential. Per our flagship philosophy we pick forward next-exponentials over trailing compounders — ROK is squarely a compounder.
Room to run (limited): the industrial-automation TAM is large but mature and slow-growing; at $52B market cap in a category that compounds mid-single-digits, there is no realistic path to a fast multibagger. The quality lever (software/ARR mix, higher-margin recurring revenue) is the real upside, and it moves slowly.
Reinvestment runway: disciplined — modest capex (~$186M FY25, ~2% of sales), heavy return of cash via buybacks and a ~1.2% dividend. This is a mature-capital-allocation profile, not a reinvest-for-hypergrowth one.
Exponential Potential: Low (3/10). Own ROK for durable mid-single-digit compounding + a slow margin/mix upgrade, not for a fast multibagger. A small, accelerating automation name would score far higher; a $52B mature leader does not.
Revenue: FY25 $8.34B, +1.0% (FY24 $8.26B; down from FY23's cyclical peak of $9.06B). The 2024–25 trough reflects a genuine automation capex downcycle; the recovery is now underway.
Margins: gross 52.5% TTM, EBITDA margin ~18.8%, operating ~19%, net 12.4% TTM. Q2 FY26 Enterprise operating margin was 22.5% (up from 19.0% a year ago) on volume, price/cost, and mix — margins are expanding as sales recover.
Earnings — read this carefully: FY25 GAAP diluted EPS was $7.67, depressed by a large Q4 non-operating charge (Q4 GAAP EPS just $1.23). The run-rate is much higher: adjusted EPS was $3.30 in Q2 FY26 alone (+32% YoY), and management guides FY26 adjusted EPS to $12.50–$13.10. Trailing GAAP P/E (~49×) therefore overstates the true multiple; the forward figures (§6) are the fair lens.
Balance sheet: total debt ~$3.65B, net debt ~$3.18B, net-debt/EBITDA ~2.2× — moderate leverage for a cyclical; interest coverage ~12×; investment-grade. ROE ~30%, ROIC ~16% (management cites adjusted ROIC 17.2%).
6. Valuation — priced in or room?
ROK is not cheap. Trailing GAAP P/E of ~49× is distorted by the FY25 charge; the honest lens is forward, and even there the stock is ~36× FY26E ($12.98) → ~32× FY27E ($14.53) → ~26× FY30E ($18.49). On management's own FY26 adjusted-EPS guide ($12.50–$13.10) the multiple is ~37–38×. EV/EBITDA is 34× and EV/sales 6.4× — rich absolute levels for a company growing revenue ~5%. The forward PEG (~4×) confirms you are paying up for quality and cyclical recovery, not for growth.
The bull's defense is that (a) margins and the software/ARR mix keep improving, lifting EPS faster than revenue, and (b) the capex cycle has further to run. Both are plausible, but neither makes the current multiple a bargain. Street targets (context): consensus $475, high $525, low $410, median $490 — and the analyst grade split is 12 Buy / 25 Hold / 2 Sell = "Hold." The Street itself is not enthusiastic. Our ~$465 base FV sits right in that consensus band. This is a quality-cyclical-at-full-price — a Watch, not a buy, at $471.70.
7. Technicals (computed from EOD price history)
Trend:up. $471.70 sits above the 50-DMA ($448) and 200-DMA ($399), with the 50 above the 200 (golden-cross posture). MACD +9.7 (positive).
Location:−4.7% off the 52-week high ($495), +43.5% off the 52-week low ($329) — a leadership industrial near its highs, with a shallow max drawdown (−4.7% from peak).
Momentum: RSI(14) 56 — constructive but not overbought (<70); no stretched-entry warning, but no oversold bargain either.
Relative strength: ROK +39.3% 12-mo vs SPY +20.6% and QQQ +30.3%; +27.9% 3-mo vs SPY +13.7%. Outperforming both the market and the Nasdaq over 12 months — the cyclical-recovery trade is working.
Read: technicals confirm the recovery but offer no valuation help. The stock is near highs, not on sale. A pullback toward the rising 50-DMA (~$448) or below would be a lower-risk entry consistent with the Watch stance.
8. Moat & competitive position
Rockwell's moat is real and durable: (1) the Allen-Bradley / Logix installed base — decades of controllers embedded in North-American factories create enormous switching costs; engineers are trained on the ecosystem and rip-and-replace is costly and risky; (2) a broad automation portfolio (devices + control software + lifecycle services) that lets it sell the whole stack; (3) a software/ARR pivot (Software & Control +20% YoY, ARR +6%) that gradually raises recurring, higher-margin revenue. The offset: it is a cyclical, capex-driven business with formidable global competitors (Siemens, Schneider Electric, ABB, Emerson, Honeywell) — several larger and more diversified than Rockwell, which is the automation pure-play.
Peer set (FMP-supplied, US industrial compounders — market cap): AMETEK $54B, Fastenal $56B, W.W. Grainger $63B, HEICO $50B, Ingersoll Rand $32B, Otis $28B, Paychex $38B, Roper $37B, Waste Connections $43B, Xylem $28B. (Note: FMP's peer list is broad "quality industrials," not automation pure-plays; ROK's truest comps are Siemens/Schneider/ABB/Emerson, not shown here.) Against this quality-industrial cohort ROK carries a premium multiple justified only by its moat and margin/mix trajectory.
9. Management, capital allocation & guidance
Capital allocation: disciplined and shareholder-friendly — modest capex (~2% of sales), a growing dividend (~1.2% yield, ~55% payout), and active buybacks (1.2M shares / $454M repurchased in Q2 FY26; ~$318M remained on the authorization). Leverage held at a moderate ~2.2× net-debt/EBITDA. In April 2026 management dissolved the Sensia JV and is excluding the divested businesses from second-half guidance — portfolio pruning, not empire-building.
Insider activity: routine. Recent Form 4s show small officer sales (SVP Lifecycle Services, Chief IP Counsel) at $426–$460, mostly tied to option exercises/RSU vesting, plus a director RSU award — normal compensation-driven activity, no alarming discretionary selling cluster in the sampled window (through 2026-07-01).
Management's own guidance (SEC 8-K, Q2 FY26 earnings release 2026-05-05 — half-weighted; this is management's self-interested framing): management raised FY26 guidance to reported sales growth 5–9% (from 3–7%), organic sales growth 5–9% (from 2–6%), reported-sales midpoint ~$8.9B, diluted EPS $11.88–$12.48 (from $10.75–$11.55) and adjusted EPS $12.50–$13.10 (from $11.40–$12.20). CEO Blake Moret cited "improving demand in warehouse automation, data center, semiconductor, and energy," while noting "capital investment remains muted in other key verticals." Total ARR +6% YoY. Treat as management's own book, half-weighted — but the raise is corroborated by the actual Q2 print (+12% sales, adj. EPS +32%), which lends it credibility.
10. Catalysts & what to watch
Next earnings: 2026-08-05 (Q3 FY26; Street EPS $3.34, revenue ~$2.24B). Key lines: organic order growth, ARR growth, and Software & Control margin — the tells for whether the recovery is broadening or stalling.
Capex cycle: the single biggest swing factor. Watch orders/book-to-bill and management's vertical-by-vertical demand commentary (data center, semi, warehouse strong; others "muted").
Software/ARR mix: continued double-digit Software & Control growth and rising ARR = the quality-upgrade thesis working.
Margins: whether Enterprise operating margin holds the mid-20s% as volume recovers.
Sensia divestiture: clean read-through on the second-half comparable-period adjustments.
Thesis tripwires (what would change the call): two consecutive quarters of organic order decline; ARR growth stalling below mid-single-digits; Enterprise operating margin compressing back toward high-teens; or a multiple re-rating that finally makes the risk/reward attractive (a move toward the ~$400s would warrant an upgrade look).
11. Key risks
Cyclicality (structural): automation demand tracks industrial capex; a slowdown hits orders, revenue, and the rich multiple simultaneously — the classic cyclical double-whammy. This is the core reason for the Watch.
Valuation / de-rating: ~36× forward EPS for ~5% revenue growth leaves little margin for a demand or margin disappointment.
Leverage + beta: net-debt/EBITDA ~2.2× and beta 1.56 amplify downside in a risk-off or recessionary tape.
Geographic concentration: ~63% North America — a US-capex tailwind today, but a concentration risk if domestic manufacturing investment cools.
Competition: larger, more diversified global rivals (Siemens, Schneider, ABB, Emerson) can pressure pricing and share.
No expert coverage: the Synthos KB has zero traceable expert views on ROK — this call has no conviction-track corroboration and rests entirely on fundamentals/quant.
12. Verdict, position sizing & monitoring
Watch. Rockwell is a genuinely high-quality, wide-moat US automation franchise executing a clean cyclical recovery — 52% gross margin, ~30% ROE, expanding Enterprise operating margin (22.5% in Q2 FY26), a raised FY26 guide, and a slow but real software/ARR mix-upgrade. What holds us back is price: at ~36× forward EPS and 34× EV/EBITDA for ~5% revenue growth, the market already pays full value, and the Street's own 12 Buy / 25 Hold / 2 Sell grade agrees this is not a screaming opportunity. Combine a rich multiple with beta 1.56, ~2.2× leverage, and a cyclical order book, and the risk/reward here is balanced-to-slightly-negative, not compelling.
Sizing:watchlist / small satellite only. No need to own it at $471.70. Build a position on either (a) a valuation reset toward the low-$400s / mid-20s× forward, or (b) confirmed order re-acceleration that upgrades the growth rate.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-08-05). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $471.70.
Single biggest risk: a cyclical capex downturn that rolls orders over while the stock still carries a ~36× forward multiple.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage of ROK in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven, and says so. Fabricated conviction is structurally impossible (claim-ID reconciliation), and none is claimed here.
Data as-of: fundamentals 2026-03-31 (Q2 FY26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: management's raised FY26 guidance (SEC 8-K, 2026-05-05) is management's own book, half-weighted by design; it is corroborated by the actual Q2 FY26 print.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").